Your browser doesn't support javascript.
loading
Preclinical in vitro and in vivo profile of a highly-attenuated, broadly efficacious pneumolysin genetic toxoid.
Thanawastien, Ann; Joyce, Kelsey E; Cartee, Robert T; Haines, Laurel A; Pelton, Stephen I; Tweten, Rodney K; Killeen, Kevin P.
Afiliación
  • Thanawastien A; Matrivax Research & Development Corporation, Boston, MA, United States.
  • Joyce KE; Matrivax Research & Development Corporation, Boston, MA, United States.
  • Cartee RT; Matrivax Research & Development Corporation, Boston, MA, United States.
  • Haines LA; Matrivax Research & Development Corporation, Boston, MA, United States.
  • Pelton SI; Boston University Schools of Medicine and Public Health, Boston Medical Center, Boston, MA, United States.
  • Tweten RK; Department of Microbiology and Immunology, University of Oklahoma Health Sciences Center, Oklahoma City, United States.
  • Killeen KP; Matrivax Research & Development Corporation, Boston, MA, United States. Electronic address: kpkilleen@matrivax.com.
Vaccine ; 39(11): 1652-1660, 2021 03 12.
Article en En | MEDLINE | ID: mdl-32532546
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Infecciones Neumocócicas / Toxoides Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: Vaccine Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Infecciones Neumocócicas / Toxoides Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: Vaccine Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos